A 2023 examine published during the journal Lancet Oncology located disruptions in care amid the pandemic also brought about an increase in late-phase diagnoses across almost all cancer kinds, together with prostate. In past times many years, the usage of biomarkers and molecular exams is speedily expanding so as to deliver the people Along with